Tsimikas, Sotirios
Funding for this research was provided by:
NHLBI (HL159156 and HL170224)
Article History
Received: 17 July 2025
Accepted: 13 September 2025
First Online: 13 October 2025
Declarations
:
: No animal subjects were used in this study. All studies with human subjects are published and followed ethical, institutional standards.
: Conflict of Interest: Dr Tsimikas is an employee of Ionis pharmaceuticals and University of California San Diego (UCSD), holds individual stock and options from Ionis, has received grant/research support paid to UCSD from the National Heart, Lung, and Blood Institute (NHLBI)/Novartis, is a consultant and receives fees/honoraria from Novartis, receives royalties from patents held by UCSD, and has ownership interest from Kleanthi and Oxitope Pharma.